- Home
- CBUS vs RVPHW Comparison
CBUS vs RVPHW Comparison
Compare CBUS & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- RVPHW
- Stock Information
- Founded
- CBUS 2010
- RVPHW 2018
- Country
- CBUS United States
- RVPHW United States
- Employees
- CBUS N/A
- RVPHW 14
- Industry
- CBUS Agricultural Chemicals
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- RVPHW Health Care
- Exchange
- CBUS Nasdaq
- RVPHW Nasdaq
- Market Cap
- CBUS 65.3M
- RVPHW N/A
- IPO Year
- CBUS 2017
- RVPHW N/A
- Fundamental
- Price
- CBUS $2.35
- RVPHW $0.06
- Analyst Decision
- CBUS Strong Buy
- RVPHW
- Analyst Count
- CBUS 3
- RVPHW 0
- Target Price
- CBUS $22.17
- RVPHW N/A
- AVG Volume (30 Days)
- CBUS 130.4K
- RVPHW 22.4K
- Earning Date
- CBUS 05-08-2025
- RVPHW 03-14-2025
- Dividend Yield
- CBUS N/A
- RVPHW N/A
- EPS Growth
- CBUS N/A
- RVPHW N/A
- EPS
- CBUS N/A
- RVPHW N/A
- Revenue
- CBUS $4,262,000.00
- RVPHW N/A
- Revenue This Year
- CBUS $105.58
- RVPHW N/A
- Revenue Next Year
- CBUS $194.76
- RVPHW N/A
- P/E Ratio
- CBUS N/A
- RVPHW N/A
- Revenue Growth
- CBUS 134.56
- RVPHW N/A
- 52 Week Low
- CBUS $1.40
- RVPHW $0.13
- 52 Week High
- CBUS $19.56
- RVPHW $0.15
- Technical
- Relative Strength Index (RSI)
- CBUS 59.91
- RVPHW N/A
- Support Level
- CBUS $1.96
- RVPHW N/A
- Resistance Level
- CBUS $2.58
- RVPHW N/A
- Average True Range (ATR)
- CBUS 0.24
- RVPHW 0.00
- MACD
- CBUS 0.06
- RVPHW 0.00
- Stochastic Oscillator
- CBUS 73.86
- RVPHW 0.00
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.